{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:47:54Z","timestamp":1790740074976,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30900534"],"award-info":[{"award-number":["30900534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2018JY0612"],"award-info":[{"award-number":["2018JY0612"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00277-020-04389-5","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T14:02:47Z","timestamp":1609596167000},"page":"715-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel tumour\u2013infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma"],"prefix":"10.1007","volume":"100","author":[{"given":"Qiqi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-7999","authenticated-orcid":false,"given":"Sha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"issue":"10","key":"4389_CR1","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M (2020) Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia 34(10):2592\u20132606","journal-title":"Leukemia"},{"issue":"4","key":"4389_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.4920","volume":"242","author":"F Lemonnier","year":"2017","unstructured":"Lemonnier F, Mak TW (2017) Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells. J Pathol 242(4):387\u2013390","journal-title":"J Pathol"},{"issue":"9","key":"4389_CR3","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Bri\u00e8re J, Raffoux E, Delmer A, Feller A, Meijer CJ, Emile JF, Bouabdallah R, Bosly A, Diebold J, Haioun C, Coiffier B, Gisselbrecht C, Gaulard P (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood 111(9):4463\u20134470","journal-title":"Blood"},{"issue":"9","key":"4389_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM (2017) Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood 129(9):1095\u20131102","journal-title":"Blood"},{"issue":"5","key":"4389_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","volume":"148","author":"L De Leval","year":"2010","unstructured":"De Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 148(5):673\u2013689","journal-title":"Br J Haematol"},{"issue":"1","key":"4389_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1309\/28YP0DELGKEJGRXG","volume":"126","author":"SH Merchant","year":"2006","unstructured":"Merchant SH, Amin MB, Viswanatha DS (2006) Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: emphasis on phenotypic aberrancies for early diagnosis. Am J Clin Pathol 126(1):29\u201338","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"4389_CR7","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L De Leval","year":"2007","unstructured":"De Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, Lamant L, Leroy K, Briere J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109(11):4952\u20134963","journal-title":"Blood"},{"issue":"2","key":"4389_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2353\/ajpath.2010.100150","volume":"177","author":"J Bruneau","year":"2010","unstructured":"Bruneau J, Canioni D, Renand A, Marafioti T, Paterson JC, Martin-Garcia N, Gaulard P, Delfau MH, Hermine O, Macintyre E (2010) Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol 177(2):570\u2013574","journal-title":"Am J Pathol"},{"issue":"2","key":"4389_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00277-018-3534-z","volume":"98","author":"Z Chen","year":"2019","unstructured":"Chen Z, Deng X, Ye Y, Gao L, Zhang W, Liu W, Zhao S (2019) Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry. Ann Hematol 98(2):391\u2013399","journal-title":"Ann Hematol"},{"issue":"1","key":"4389_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368(1):7\u201313","journal-title":"Cancer Lett"},{"key":"4389_CR11","doi-asserted-by":"crossref","unstructured":"Wu T, Dai Y(2017) Tumor microenvironment and therapeutic response. Cancer Lett 38761-68","DOI":"10.1016\/j.canlet.2016.01.043"},{"key":"4389_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ctrv.2017.04.005","volume":"57","author":"C Solinas","year":"2017","unstructured":"Solinas C, Ceppi M, Lambertini M, Scartozzi M, Buisseret L, Garaud S, Fumagalli D, de Azambuja E, Salgado R, Sotiriou C, Willard-Gallo K, Ignatiadis M (2017) Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: a meta-analysis of randomized controlled trials. Cancer Treat Rev 57:8\u201315","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"4389_CR13","doi-asserted-by":"publisher","first-page":"15621","DOI":"10.18632\/oncotarget.14919","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Wang J, Chen R, Bai Y, Lu X (2017) The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Oncotarget 8(9):15621\u201315631","journal-title":"Oncotarget"},{"issue":"17","key":"4389_CR14","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1158\/1078-0432.CCR-16-3107","volume":"23","author":"M Altan","year":"2017","unstructured":"Altan M, Pelekanou V, Schalper KA, Toki M, Gaule P, Syrigos K, Herbst RS, Rimm DL (2017) B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes. Cli Cancer Res: Off J Am Assoc Cancer Res 23(17):5202\u20135209","journal-title":"Cli Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"1","key":"4389_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/cancers11010039","volume":"11","author":"RC Miksch","year":"2019","unstructured":"Miksch RC, Schoenberg MB, Weniger M, Bosch F, Ormanns S, Mayer B, Werner J, Bazhin AV, D'Haese JG (2019) Prognostic impact of tumor-infiltrating lymphocytes and neutrophils on survival of patients with upfront resection of pancreatic cancer. Cancers (Basel) 11(1):39","journal-title":"Cancers (Basel)"},{"issue":"5","key":"4389_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/ijc.30138","volume":"139","author":"J Berntsson","year":"2016","unstructured":"Berntsson J, Nodin B, Eberhard J, Micke P, Jirstrom K (2016) Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Int J Cancer 139(5):1129\u20131139","journal-title":"Int J Cancer"},{"issue":"10","key":"4389_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/modpathol.2016.113","volume":"29","author":"M Alikhan","year":"2016","unstructured":"Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G (2016) Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(\u2212\/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Modern Pathol: Off J United States Can Acad Pathol 29(10):1173\u20131182","journal-title":"Modern Pathol: Off J United States Can Acad Pathol"},{"issue":"1","key":"4389_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hon.2080","volume":"32","author":"A Singh","year":"2014","unstructured":"Singh A, Schabath R, Ratei R, Stroux A, Klemke CD, Nebe T, Florcken A, van Lessen A, Anagnostopoulos I, Dorken B, Ludwig WD, Pezzutto A, Westermann J (2014) Peripheral blood sCD3(\u2212) CD4(+) T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma. Hematol Oncol 32(1):16\u201321","journal-title":"Hematol Oncol"},{"issue":"10","key":"4389_CR19","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/1097-0142(19871115)60:10<2412::AID-CNCR2820601010>3.0.CO;2-F","volume":"60","author":"G Pizzolo","year":"1987","unstructured":"Pizzolo G, Vinante F, Agostini C, Zambello R, Trentin L, Masciarelli M, Chilosi M, Benedetti F, Dazzi F, Todeschini G et al (1987) Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer 60(10):2412\u20132418","journal-title":"Cancer"},{"key":"4389_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-62703-727-3_16","volume":"1102","author":"T Schatton","year":"2014","unstructured":"Schatton T, Scolyer RA, Thompson JF, Mihm MC Jr (2014) Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. Methods Mol Biol (Clifton, NJ) 1102:287\u2013324","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"27","key":"4389_CR21","doi-asserted-by":"publisher","first-page":"e11387","DOI":"10.1097\/MD.0000000000011387","volume":"97","author":"PC Yu","year":"2018","unstructured":"Yu PC, Long D, Liao CC, Zhang S (2018) Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer. Medicine 97(27):e11387","journal-title":"Medicine"},{"issue":"1","key":"4389_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/ejh.13239","volume":"103","author":"E Crickx","year":"2019","unstructured":"Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O, Roos-Weil D, de Leval L, Parrens M, Michel M, Dupuis J, Le Bras F, Fataccioli V, Martin-Garcia N, Godeau B, Haioun C, Gaulard P, Mahevas M (2019) Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol 103(1):35\u201342","journal-title":"Eur J Haematol"},{"issue":"2","key":"4389_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4132\/jptm.2016.01.12","volume":"50","author":"CH Choi","year":"2016","unstructured":"Choi CH, Park YH, Lim JH, Choi SJ, Kim L, Park IS, Han JY, Kim JM, Chu YC (2016) Prognostic implication of semi-quantitative Immunohistochemical assessment of CD20 expression in diffuse large B-cell lymphoma. J Pathol Transl Med 50(2):96\u2013103","journal-title":"J Pathol Transl Med"},{"issue":"52","key":"4389_CR24","doi-asserted-by":"publisher","first-page":"20878","DOI":"10.1073\/pnas.0709205105","volume":"104","author":"JD Bouaziz","year":"2007","unstructured":"Bouaziz JD, Yanaba K, Venturi GM, Wang Y, Tisch RM, Poe JC, Tedder TF (2007) Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A 104(52):20878\u201320883","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4389_CR25","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","volume":"176","author":"A Crawford","year":"2006","unstructured":"Crawford A, Macleod M, Schumacher T, Corlett L, Gray D (2006) Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol (Baltimore, Md : 1950) 176(6):3498\u20133506","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"12","key":"4389_CR26","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","volume":"18","author":"JS Nielsen","year":"2012","unstructured":"Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, Nelson BH (2012) CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Cli Cancer Res : Off J Am Assoc Cancer Res 18(12):3281\u20133292","journal-title":"Cli Cancer Res : Off J Am Assoc Cancer Res"},{"issue":"1","key":"4389_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","volume":"7","author":"K Hladikova","year":"2019","unstructured":"Hladikova K, Koucky V, Boucek J, Laco J, Grega M, Hodek M, Zabrodsky M, Vosmik M, Rozkosova K, Vosmikova H, Celakovsky P, Chrobok V, Ryska A, Spisek R, Fialova A (2019) Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells. J Immunother Cancer 7(1):261","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4389_CR28","doi-asserted-by":"publisher","first-page":"e13923","DOI":"10.1097\/MD.0000000000013923","volume":"98","author":"X Xu","year":"2019","unstructured":"Xu X, Tan Y, Qian Y, Xue W, Wang Y, Du J, Jin L, Ding W (2019) Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: a meta-analysis. Medicine 98(2):e13923","journal-title":"Medicine"},{"issue":"1","key":"4389_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-018-0942-x","volume":"20","author":"M Schmidt","year":"2018","unstructured":"Schmidt M, Weyer-Elberich V, Hengstler JG, Heimes AS, Almstedt K, Gerhold-Ay A, Lebrecht A, Battista MJ, Hasenburg A, Sahin U, Kalogeras KT, Kellokumpu-Lehtinen PL, Fountzilas G, Wirtz RM, Joensuu H (2018) Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population. Breast Cancer res: BCR 20(1):15","journal-title":"Breast Cancer res: BCR"},{"issue":"5","key":"4389_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1086\/605292","volume":"49","author":"JA Aberg","year":"2009","unstructured":"Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE (2009) Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis: Off Publ Infect Dis Soc Am 49(5):651\u2013681","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"5","key":"4389_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2217\/fon.09.28","volume":"5","author":"GM Clifford","year":"2009","unstructured":"Clifford GM, Franceschi S (2009) Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol (London, England) 5(5):669\u2013678","journal-title":"Future Oncol (London, England)"},{"issue":"18","key":"4389_CR32","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","volume":"360","author":"MM Kitahata","year":"2009","unstructured":"Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360(18):1815\u20131826","journal-title":"N Engl J Med"},{"issue":"2","key":"4389_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2567.2006.02452.x","volume":"120","author":"H Huang","year":"2007","unstructured":"Huang H, Hao S, Li F, Ye Z, Yang J, Xiang J (2007) CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes. Immunology 120(2):148\u2013159","journal-title":"Immunology"},{"issue":"13","key":"4389_CR34","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1073\/pnas.0801003105","volume":"105","author":"S Oh","year":"2008","unstructured":"Oh S, Perera LP, Terabe M, Ni L, Waldmann TA, Berzofsky JA (2008) IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci U S A 105(13):5201\u20135206","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4389_CR35","doi-asserted-by":"crossref","unstructured":"Crotty S(2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29621\u2013663","DOI":"10.1146\/annurev-immunol-031210-101400"},{"issue":"2","key":"4389_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clml.2016.11.005","volume":"17","author":"J Judd","year":"2017","unstructured":"Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T (2017) Low level of blood CD4(+) T cells is an independent predictor of inferior progression-free survival in diffuse large B-cell lymphoma. Clin Lymphoma, Myeloma Leuk 17(2):83\u201388","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"issue":"7","key":"4389_CR37","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothe F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart M, Sotiriou C, Willard-Gallo K (2013) CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 123(7):2873\u20132892","journal-title":"J Clin Invest"},{"issue":"6184","key":"4389_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, Parkhurst MR, Yang JC, Rosenberg SA (2014) Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344(6184):641\u2013645","journal-title":"Science"},{"issue":"19","key":"4389_CR39","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"I Javeed","year":"2014","unstructured":"Javeed I, George W, Chao W, Andreas R, Gascoyne RD, Weisenburger DD, Greiner TC, Lynette S, Shuangping G, Wilcox RA (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123(19):2915","journal-title":"Blood"},{"issue":"12","key":"4389_CR40","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-18-4085","volume":"25","author":"B Li","year":"2019","unstructured":"Li B, Cui Y, Nambiar DK, Sunwoo JB, Li R (2019) The immune subtypes and landscape of squamous cell carcinoma. Cli Cancer Res: Off J Am Assoc Cancer Res 25(12):3528\u20133537","journal-title":"Cli Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"6","key":"4389_CR41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/2326-6066.CIR-18-0822","volume":"7","author":"L Danilova","year":"2019","unstructured":"Danilova L, Ho WJ, Zhu Q, Vithayathil T, De Jesus-Acosta A, Azad NS, Laheru DA, Fertig EJ, Anders R, Jaffee EM, Yarchoan M (2019) Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival. Cancer Immunol Res 7(6):886\u2013895","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"4389_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000064361","volume":"69","author":"T Igarashi","year":"2002","unstructured":"Igarashi T, Takahashi H, Tobe T, Suzuki H, Mizoguchi K, Nakatsu HO, Ito H (2002) Effect of tumor-infiltrating lymphocyte subsets on prognosis and susceptibility to interferon therapy in patients with renal cell carcinoma. Urol Int 69(1):51\u201356","journal-title":"Urol Int"},{"issue":"13","key":"4389_CR43","first-page":"5132","volume":"61","author":"O Nakano","year":"2001","unstructured":"Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H (2001) Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 61(13):5132\u20135136","journal-title":"Cancer Res"},{"issue":"7","key":"4389_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, Salgado R, Byrne DJ, Teo ZL, Dushyanthen S, Byrne A, Wein L, Luen SJ, Poliness C, Nightingale SS, Skandarajah AS, Gyorki DE, Thornton CM, Beavis PA, Fox SB, Darcy PK, Speed TP, Mackay LK, Neeson PJ, Loi S (2018) Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med 24(7):986\u2013993","journal-title":"Nat Med"},{"issue":"2","key":"4389_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N, Vose JM (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol Off J Am Soc Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"4389_CR46","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ajh.25513","volume":"94","author":"JM Zain","year":"2019","unstructured":"Zain JM (2019) Aggressive T-cell lymphomas: 2019 updates on diagnosis, risk stratification, and management. Am J Hematol 94(8):929\u2013946","journal-title":"Am J Hematol"},{"issue":"3","key":"4389_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1200\/JOP.18.00511","volume":"15","author":"AJ Moskowitz","year":"2019","unstructured":"Moskowitz AJ (2019) Practical treatment approach for Angioimmunoblastic T-cell lymphoma. J Oncol Pract 15(3):137\u2013143","journal-title":"J Oncol Pract"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04389-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T02:57:12Z","timestamp":1670641032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04389-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4389"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04389-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"27 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}